Antidote Therapeutics, Inc
Antidote Therapeutics, Inc
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers | Arterial Occlusive Diseases, Chemically-Induced Disorders, cardiovascular disorder, nicotine dependence, psychiatric disorder, substance-related disorder, thromboangiitis obliterans, vascular disorder, vasculitis | Recruiting | Phase 1 | 2025-10-15 | NCT07215923 |